{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:47:03Z","timestamp":1789001223809,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,9,26]],"date-time":"2017-09-26T00:00:00Z","timestamp":1506384000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"China National Natural Science Foundation","doi-asserted-by":"crossref","award":["91442119"],"award-info":[{"award-number":["91442119"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s10067-017-3844-x","type":"journal-article","created":{"date-parts":[[2017,9,26]],"date-time":"2017-09-26T01:41:52Z","timestamp":1506390112000},"page":"2565-2571","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Association between primary biliary cholangitis and osteoporosis: meta-analysis"],"prefix":"10.1007","volume":"36","author":[{"given":"Junyu","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,26]]},"reference":[{"key":"3844_CR1","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1136\/gutjnl-2015-310593","volume":"64","author":"U Beuers","year":"2015","unstructured":"Beuers U, Gershwin ME, Gish RG et al (2015) Changing nomenclature for PBC: from \u2018cirrhosis\u2019 to \u2018cholangitis\u2019. Gut 64:1671\u20131672","journal-title":"Gut"},{"key":"3844_CR2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-pathol-020712-164014","volume":"8","author":"GM Hirschfield","year":"2013","unstructured":"Hirschfield GM, Gershwin ME (2013) The immunobiology and pathophysiology of primary biliary cirrhosis. Annu Rev Pathol 8:303\u2013330","journal-title":"Annu Rev Pathol"},{"key":"3844_CR3","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","volume":"386","author":"EJ Carey","year":"2015","unstructured":"Carey EJ, Ali AH, Lindor KD (2015) Primary biliary cirrhosis. Lancet 386:1565\u20131575","journal-title":"Lancet"},{"key":"3844_CR4","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.gastro.2012.12.005","volume":"144","author":"M Carbone","year":"2013","unstructured":"Carbone M, Mells GF, Pells G et al (2013) Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid. Gastroenterology 144:560\u2013569 e567 quiz e513-564","journal-title":"Gastroenterology"},{"key":"3844_CR5","first-page":"82","volume":"9","author":"J Raszeja-Wyszomirska","year":"2014","unstructured":"Raszeja-Wyszomirska J, Miazgowski T (2014) Osteoporosis in primary biliary cirrhosis of the liver. Prz Gastroenterol 9:82\u201387","journal-title":"Prz Gastroenterol"},{"key":"3844_CR6","volume-title":"Assessment of osteoporosis at the primary health care level","author":"JA Kanis","year":"2008","unstructured":"Kanis JA (2008) Assessment of osteoporosis at the primary health care level. Technical Report WHO Collaborating Centre for Metabolic Bone Diseases University of Sheffield, UK"},{"key":"3844_CR7","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R, National Osteoporosis F (2014) Clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int 25:2359\u20132381","journal-title":"Osteoporos Int"},{"key":"3844_CR8","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200084","volume":"13","author":"TP Staa van","year":"2002","unstructured":"van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777\u2013787","journal-title":"Osteoporos Int"},{"key":"3844_CR9","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/art.22294","volume":"56","author":"F Vries De","year":"2007","unstructured":"De Vries F, Bracke M, Leufkens HG, Lammers JW, Cooper C, Van Staa TP (2007) Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum 56:208\u2013214","journal-title":"Arthritis Rheum"},{"key":"3844_CR10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1472-6823-14-33","volume":"14","author":"G Leidig-Bruckner","year":"2014","unstructured":"Leidig-Bruckner G, Grobholz S, Bruckner T, Scheidt-Nave C, Nawroth P, Schneider JG (2014) Prevalence and determinants of osteoporosis in patients with type 1 and type 2 diabetes mellitus. BMC Endocr Disord 14:33","journal-title":"BMC Endocr Disord"},{"key":"3844_CR11","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1053\/j.gastro.2003.09.027","volume":"125","author":"TP Staa van","year":"2003","unstructured":"van Staa TP, Cooper C, Brusse LS, Leufkens H, Javaid MK, Arden NK (2003) Inflammatory bowel disease and the risk of fracture. Gastroenterology 125:1591\u20131597","journal-title":"Gastroenterology"},{"issue":"1436\u20131443","key":"3844_CR12","first-page":"e1431","volume":"164","author":"S Laakso","year":"2014","unstructured":"Laakso S, Valta H, Verkasalo M, Toiviainen-Salo S, Makitie O (2014) Compromised peak bone mass in patients with inflammatory bowel disease\u2014a prospective study. J Pediatr 164(1436\u20131443):e1431","journal-title":"J Pediatr"},{"key":"3844_CR13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.1840140215","volume":"14","author":"R Eastell","year":"1991","unstructured":"Eastell R, Dickson ER, Hodgson SF, Wiesner RH, Porayko MK, Wahner HW, Cedel SL, Riggs BL, Krom RA (1991) Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology 14:296\u2013300","journal-title":"Hepatology"},{"key":"3844_CR14","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0168-8278(01)00144-1","volume":"35","author":"KV Menon","year":"2001","unstructured":"Menon KV, Angulo P, Weston S, Dickson ER, Lindor KD (2001) Bone disease in primary biliary cirrhosis: independent indicators and rate of progression. J Hepatol 35:316\u2013323","journal-title":"J Hepatol"},{"key":"3844_CR15","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jhep.2004.11.035","volume":"42","author":"N Guanabens","year":"2005","unstructured":"Guanabens N, Pares A, Ros I, Caballeria L, Pons F, Vidal S, Monegal A, Peris P, Rodes J (2005) Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis. J Hepatol 42:573\u2013577","journal-title":"J Hepatol"},{"key":"3844_CR16","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.3748\/wjg.v11.i34.5347","volume":"11","author":"A Floreani","year":"2005","unstructured":"Floreani A, Mega A, Camozzi V, Baldo V, Plebani M, Burra P, Luisetto G (2005) Is osteoporosis a peculiar association with primary biliary cirrhosis? World J Gastroenterol 11:5347\u20135350","journal-title":"World J Gastroenterol"},{"key":"3844_CR17","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00296-009-1071-8","volume":"30","author":"G Wariaghli","year":"2010","unstructured":"Wariaghli G, Mounach A, Achemlal L, Benbaghdadi I, Aouragh A, Bezza A, El Maghraoui A (2010) Osteoporosis in chronic liver disease: a case-control study. Rheumatol Int 30:893\u2013899","journal-title":"Rheumatol Int"},{"key":"3844_CR18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/gut.49.2.282","volume":"49","author":"J Newton","year":"2001","unstructured":"Newton J, Francis R, Prince M, James O, Bassendine M, Rawlings D, Jones D (2001) Osteoporosis in primary biliary cirrhosis revisited. Gut 49:282\u2013287","journal-title":"Gut"},{"key":"3844_CR19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1590-8658(03)00078-1","volume":"35","author":"E Solerio","year":"2003","unstructured":"Solerio E, Isaia G, Innarella R, Di Stefano M, Farina M, Borghesio E, Framarin L, Rizzetto M, Rosina F (2003) Osteoporosis: still a typical complication of primary biliary cirrhosis? Dig Liver Dis 35:339\u2013346","journal-title":"Dig Liver Dis"},{"key":"3844_CR20","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/01.mcg.0000248017.31386.39","volume":"42","author":"A Benetti","year":"2008","unstructured":"Benetti A, Crosignani A, Varenna M, Giussani CS, Allocca M, Zuin M, Podda M, Battezzati PM (2008) Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation: a controlled longitudinal study. J Clin Gastroenterol 42:306\u2013311","journal-title":"J Clin Gastroenterol"},{"key":"3844_CR21","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603\u2013605","journal-title":"Eur J Epidemiol"},{"key":"3844_CR22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557\u2013560","journal-title":"BMJ"},{"key":"3844_CR23","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2036.2004.02089.x","volume":"20","author":"JR Boulton-Jones","year":"2004","unstructured":"Boulton-Jones JR, Fenn RM, West J, Logan RF, Ryder SD (2004) Fracture risk of women with primary biliary cirrhosis: no increase compared with general population controls. Aliment Pharmacol Ther 20:551\u2013557","journal-title":"Aliment Pharmacol Ther"},{"key":"3844_CR24","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1053\/j.gastro.2006.09.012","volume":"131","author":"M Solaymani-Dodaran","year":"2006","unstructured":"Solaymani-Dodaran M, Card TR, Aithal GP, West J (2006) Fracture risk in people with primary biliary cirrhosis: a population-based cohort study. Gastroenterology 131:1752\u20131757","journal-title":"Gastroenterology"},{"key":"3844_CR25","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/2042018816641351","volume":"7","author":"G Handzlik-Orlik","year":"2016","unstructured":"Handzlik-Orlik G, Holecki M, Wilczynski K, Dulawa J (2016) Osteoporosis in liver disease: pathogenesis and management. Ther Adv Endocrinol Metab 7:128\u2013135","journal-title":"Ther Adv Endocrinol Metab"},{"key":"3844_CR26","first-page":"185","volume":"11","author":"A Gatta","year":"2014","unstructured":"Gatta A, Verardo A, Di Pascoli M, Giannini S, Bolognesi M (2014) Hepatic osteodystrophy. Clin Cases Miner Bone Metab 11:185\u2013191","journal-title":"Clin Cases Miner Bone Metab"},{"key":"3844_CR27","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrgastro.2009.166","volume":"6","author":"IA Nakchbandi","year":"2009","unstructured":"Nakchbandi IA, van der Merwe SW (2009) Current understanding of osteoporosis associated with liver disease. Nat Rev Gastroenterol Hepatol 6:660\u2013670","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3844_CR28","first-page":"602321","volume":"2013","author":"LN Khanh vinh","year":"2013","unstructured":"Khanh vinh LN, Nguyen LT (2013) The role of vitamin d in primary biliary cirrhosis: possible genetic and cell signaling mechanisms. Gastroenterol Res Pract 2013:602321","journal-title":"Gastroenterol Res Pract"},{"key":"3844_CR29","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/jhep.2002.30084","volume":"35","author":"A Vogel","year":"2002","unstructured":"Vogel A, Strassburg CP, Manns MP (2002) Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology 35:126\u2013131","journal-title":"Hepatology"},{"key":"3844_CR30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/apt.13244","volume":"42","author":"GY Guo","year":"2015","unstructured":"Guo GY, Shi YQ, Wang L et al (2015) Serum vitamin D level is associated with disease severity and response to ursodeoxycholic acid in primary biliary cirrhosis. Aliment Pharmacol Ther 42:221\u2013230","journal-title":"Aliment Pharmacol Ther"},{"key":"3844_CR31","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jhep.2005.05.034","volume":"43","author":"AR Moschen","year":"2005","unstructured":"Moschen AR, Kaser A, Stadlmann S, Millonig G, Kaser S, Muhllechner P, Habior A, Graziadei I, Vogel W, Tilg H (2005) The RANKL\/OPG system and bone mineral density in patients with chronic liver disease. J Hepatol 43:973\u2013983","journal-title":"J Hepatol"},{"key":"3844_CR32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF03179904","volume":"56","author":"A Cemborain","year":"2000","unstructured":"Cemborain A, Castilla-Cortazar I, Garcia M, Muguerza B, Delgado G, Diaz-Sanchez M, Picardi A (2000) Effects of IGF-I treatment on osteopenia in rats with advanced liver cirrhosis. J Physiol Biochem 56:91\u201399","journal-title":"J Physiol Biochem"},{"key":"3844_CR33","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1172\/JCI117959","volume":"95","author":"CH Janes","year":"1995","unstructured":"Janes CH, Dickson ER, Okazaki R, Bonde S, McDonagh AF, Riggs BL (1995) Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest 95:2581\u20132586","journal-title":"J Clin Invest"},{"key":"3844_CR34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2362.2009.02230.x","volume":"40","author":"S Ruiz-Gaspa","year":"2010","unstructured":"Ruiz-Gaspa S, Guanabens N, Enjuanes A et al (2010) Lithocholic acid downregulates vitamin D effects in human osteoblasts. Eur J Clin Investig 40:25\u201334","journal-title":"Eur J Clin Investig"},{"key":"3844_CR35","doi-asserted-by":"crossref","first-page":"S214","DOI":"10.1016\/j.bone.2010.04.291","volume":"47","author":"S Ruiz-Gasp\u00e0","year":"2010","unstructured":"Ruiz-Gasp\u00e0 S, Martinez-Ferrer A, Enjuanes A, Peris P, Osaba MJMD, Alvarez L, Monegal A, Combalia A, Par\u00e9s A, Gua\u00f1abens N (2010) High bilirubin reduces cell survival and differentiation of primary human osteoblasts. Is this effect applicable to the serum of chronic cholestatic patients? Bone 47:S214\u2013S215","journal-title":"Bone"},{"key":"3844_CR36","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/27376","volume":"395","author":"JM Friedman","year":"1998","unstructured":"Friedman JM, Halaas JL (1998) Leptin and the regulation of body weight in mammals. Nature 395:763\u2013770","journal-title":"Nature"},{"key":"3844_CR37","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1046\/j.1440-1746.2001.02631.x","volume":"16","author":"S Ormarsdottir","year":"2001","unstructured":"Ormarsdottir S, Ljunggren O, Mallmin H, Olofsson H, Blum WF, Loof L (2001) Inverse relationship between circulating levels of leptin and bone mineral density in chronic liver disease. J Gastroenterol Hepatol 16:1409\u20131414","journal-title":"J Gastroenterol Hepatol"},{"key":"3844_CR38","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/00042737-200509000-00007","volume":"17","author":"F Szalay","year":"2005","unstructured":"Szalay F, Folhoffer A, Horvath A et al (2005) Serum leptin, soluble leptin receptor, free leptin index and bone mineral density in patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol 17:923\u2013928","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3844_CR39","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.20866","volume":"42","author":"CO Zein","year":"2005","unstructured":"Zein CO, Jorgensen RA, Clarke B, Wenger DE, Keach JC, Angulo P, Lindor KD (2005) Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trial. Hepatology 42:762\u2013771","journal-title":"Hepatology"},{"key":"3844_CR40","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1002\/hep.26466","volume":"58","author":"N Guanabens","year":"2013","unstructured":"Guanabens N, Monegal A, Cerda D, Muxi A, Gifre L, Peris P, Pares A (2013) Randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosis. Hepatology 58:2070\u20132078","journal-title":"Hepatology"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-017-3844-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3844-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3844-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T11:40:20Z","timestamp":1659526820000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-017-3844-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,26]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["3844"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3844-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,26]]}}}